AMA CPT® Assistant - 2020 Issue 6 (June)
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV and SARS-CoV-2) Laboratory Testing (November 2020)
November 2020 Special Edition Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV and SARS-CoV-2) Laboratory Testing As the coronavirus (COVID-19) pandemic continues and responses to the disease continue to evolve, the American Medical Association (AMA) Current Procedural Terminology (CPT®) Editorial Panel convened a special meeting to approve additional codes specific to laboratory testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]). To address the ongoing clinical need to report testing, the CPT Editorial Panel has added one new Category I code (87426) to provide increased specificity for reporting immunoassay antigen testing and two new proprietary laboratory analyses...
Subscribe or sign in to view the full article.
Article Overview
This November 2020 CPT Assistant special edition explains laboratory testing guidance tied to SARS-CoV and SARS-CoV-2 in the context of the evolving COVID-19 pandemic. It is aimed at coding and laboratory billing professionals who need to understand the scope of newly added CPT and PLA laboratory test entries, the related appendix references, and the clinical context in which the article presents these updates. The article also discusses how the AMA presented and organized the new testing entries within the CPT code set.
Why This Topic Matters
Laboratory testing for COVID-19 evolved rapidly, and coding professionals needed timely updates to track new CPT and PLA entries and their placement in the code set. This article helps readers identify which testing topics and code-set changes are covered in the November 2020 guidance.
Article Sections
-
November 2020 Special Edition
Introductory framing for the special edition and its focus on laboratory testing updates tied to SARS-CoV and SARS-CoV-2.
-
Microbiology
CPT microbiology laboratory testing updates are presented, including the broader context for newly added coronavirus-related testing entries.
-
Proprietary Laboratory Analyses
PLA laboratory testing entries and their placement within the CPT framework are discussed, along with related appendix references and clinical presentation context.
What You Will Learn
- How the article frames SARS-CoV and SARS-CoV-2 laboratory testing updates within CPT
- Which broad CPT content areas are discussed in connection with coronavirus testing
- How the article organizes newly added laboratory testing entries and related appendix references
- What kinds of clinical and laboratory topics are used to illustrate the new testing entries
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance teams
- Pathology and laboratory specialists
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com